Moneycontrol PRO
you are here: HomeNewsTrendsHealth

65.5% of 2nd dose eligible beneficiaries received the jab as per CoWIN portal: Govt

Responding to a question of Rajya Sabha MP M V Shreyams Kumar, Minister of State for Health Bharati Pawar said as on July 25, about 34.04 crore persons have received at least first dose of COVID-19 vaccine.

July 28, 2021 / 05:51 PM IST
Representative image

Representative image

About 65.5 percent of second dose eligible beneficiaries aged 18 years and above have received the second dose of Covid vaccine as per CoWIN portal, the health ministry said on Wednesday.

Responding to a question of Rajya Sabha MP M V Shreyams Kumar, Minister of State for Health Bharati Pawar said as on July 25, about 34.04 crore persons have received at least first dose of COVID-19 vaccine.

"As on July 25, 2021, 65.5 per cent of second dose eligible beneficiaries aged 18 years and above have received 2nd dose of Covid vaccine as per CoWIN portal," Pawar said in a written reply in Rajya Sabha.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

She further said that regular review meetings are held with states and union territories to review all aspects of the vaccination drive, including vaccination dose coverage, among various categories of people and advisories on prioritising the second dose of Covid vaccination to increase its coverage have been shared with states and UTs.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"The government has been providing free supply of vaccines to states/UTs for administration to prioritized beneficiaries as recommended by NEGVAC. Advance visibility of these allocations i.e. the total doses of vaccine that would be available to a state/UT, are provided to states/UTs 15 days in advance so as to enable states/UTs to prepare plan for acceleration of vaccination coverage while being cognizant of the available vaccines," Pawar said.

She said it is expected that beneficiaries aged 18 years and above will be vaccinated by December this year.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Jul 28, 2021 05:51 pm
Sections
ISO 27001 - BSI Assurance Mark